Just another afternoon 3PM selloff, with large number shares dumped at market. Retail investors bid it up til 3 PM. It seems to work for whomever is trying to lower the pps. 2/26 and about 4/26 will be announcement dates where we, yawn, once again set records with massive revenue/earnings growth. A few studies probably going on, but revenues are about to really start accelerating.
Good post. I can tell you I use the product. It works very well for wound healing, as a shield to promote bone growth in bone grafting, prevent adhesions, decrease inflammation, as a nerve wrap and more. The healing process is the same no matter what part of the body and the growth factors modulate/promote this process. Recent animal studies show repair of heart muscle after infarct and other muscle as well and this is very important, exciting news. I ask many of my colleagues at the hospital and they have never heard of Amniofix/Epifix, yet these products could be used in neurosurgery, urology, Ob-Gyn, general surgery, plastics, orthopedics, hand surgery, dermatology, hair transplants, wound care and injectables (plantar, achilles, shoulder, bursa, knee and other joints etc) and dental.
You get the point, we have not even hit the growth curve for revenue yet. I could see this company doing 1 billion in sales in 4-5 years. Revenues are about to start accelerating, but what does that mean for the stock price and institutional investors? Time will bring the smart institutional investors back and there are companies that have stated biologics/stem cell companies are a PRIORITY for them and they are buying companies now to gain entry in those fields. I have bought so many times, I average about 6/share, but I am holding until the end for the stated reasons. I look at the current price action and SMH as I know what these products can do.
Mary who has a hedge fund husband and who decided Mimedx needed BLA for injectable and surprise untitled published letter. The info was relayed to me by investor DE. Anyone else hear? If so, GO Pete
Candy, you seem to have some OCD regarding Mimedx and Orgo. There is a connection. Come clean. The truth will set you free.
Orgo CEO and compliance officer left like rats on a sinking ship. Guilty. They might cooperate to save their skin. Candy what is your position at Orgo?
Mimedx products are highly effective, easy to use, long shelf life and less expensive than the competition. Revenues will accelerate going forward, even quarter one and earnings also. The question is do WTH is going on here. A larger company will buy Mimedx to get these fabulous products, I believe the IG HHS subpoena is BS and FDA requirements bogus considering other biologics don't have similar requirements. However, all Mimedx has to do is start at phase 2B BLA for the injectable and that isn't so bad with quick approval likely. So, I agree here just do it.
Apligraf/dermagraf are inferior, more expensive and difficult to use products. Orgo is like a flailing, drowning swimmer grasping at anything trying to stay afloat. Mimedx has so many products that are starting to roll, it is dismaying. Several new medical indications rolling and each with huge markets. Urology, potential 200,000 cases per year, Spinal approximately 140,000 cases per year, OB-GYN big market, wound care-continuing to grow and taking Orgo market share and dental, possible 400,000 grafts per year. There are many other exciting areas like heart, collagen to deliver antimicrobial/antifungals or cancer fighting drugs to a body site, vascular shield and so on.
This company is a biologic/stem cell and a priority for larger companies at this time. Management is growing the company rapidly and companies like Orgo, along with their harassment will go away soon.
Yep, still a big part of future. It will throw revenues into hyperdrive. It's not in question at all, but there are BLA trials starting at 2b to be done this spring prior to being able to advertise and promote the product. It is on the market now. Revenue 2015 200 million and 2016 300 million. Got it Candy?
Company is doing fine and new products/indications coming on line will increase revenue/earnings/guidance over the next several quarters. We are fighting a short term image problem related to an unethical competitor known for their unscrupulous/illegal activities. That problem is being negated. Over the next several months, these new applications will develop and the stock price will achieve new all time highs. Look for companies who have made biologics/stem cell companies a priority in their plans, to make an aggressive move for Mimedx over the next 18 months.
It's not an issue at all this year. Significant new revenue on the way as discussed previously. Injectable may be needed for 2016 growth, but could hit 300 million in 2016 without injectable. Go Patriots
You're quoting that loser, Suraj? Mimedx USA biologics, stem cell company and the multiple should be 7-10. Those aren't headwinds,they are tailwinds and the next 3 months will reveal shock and awe.
Agree Doc, these lawyers commit libel or fraud and nothing is done about these bogus actions. The average investor might pass on investing or as your friends said they aren't sure about trying a product because of these headlines. Can the company have libelous headlines removed? On another note, your friends are doing a diservice to their patients not using Amniofix. If I had a prostatectomy with bad outcome and Amniofix wasn't used, I would be talking to an attorney.
Revenues will begin to accelerate this summer.Companies are on the prowl for Biologics (stem cell companies). Those buying here will find themselves fortunate over the next 12 months.
This confirms a previous study from Jacksonville showing 95% return of nerve function in robotic prostatectomy using Amniofix nerve wrap versus only 50% in men who did not get the Amniofix nerve wrap. This is very big and every man undergoing prostatectomy should have the Amniofix nerve wrap as a standard of care. This information needs to be disseminated quickly. Plus the fact of less incontinence using the Amniofix nerve wrap makes it a must.
Yes, listen to st bite. I would like to see good, rational comments on the company or stock price. There is nothing, but a short term manufactured perception problem. If it makes you feel better, I bought more Epifix today.